Sign Up to like & get
recommendations!
3
Published in 2022 at "Cancer Communications"
DOI: 10.1002/cac2.12244
Abstract: Second‐generation programmed cell death‐protein 1/programmed death‐ligand 1 (PD‐1/PD‐L1) inhibitors, such as bintrafusp alfa (M7824), SHR‐1701, and YM101, have been developed to simultaneously block PD‐1/PD‐L1 and transforming growth factor‐beta/transforming growth factor‐beta receptor (TGF‐β/TGF‐βR). Consequently, it is…
read more here.
Keywords:
cancer;
shr 1701;
lung cancer;
protein ... See more keywords